These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 2111468)

  • 21. Oral complications of cancer therapies. Infectious and noninfectious systemic consequences.
    Wingard JR
    NCI Monogr; 1990; (9):21-6. PubMed ID: 2188156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral complications of cancer therapy.
    Redding SW
    Tex Med; 2003 May; 99(5):54-7. PubMed ID: 12772642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Standards, Options and Recommendations (SOR) for the surveillance and the prevention of cross infections in oncology. Fédération Nationale des Centres de Lutte Contre le Cancer].
    Pottecher B; Herbrecht R; Blanc-Vincent MP; Bussy Malgrange V; Escande MC; Fuhrmann C; Crokaert F; Gory-Delabaere G; Senet JM; Lesimple T; Raveneau J; Béal J; Biron P; Viot M
    Bull Cancer; 2000 Jul; 87(7-8):557-91. PubMed ID: 10969214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Healthcare epidemiology: active surveillance cultures and contact precautions for control of multidrug-resistant organisms: ethical considerations.
    Santos RP; Mayo TW; Siegel JD
    Clin Infect Dis; 2008 Jul; 47(1):110-6. PubMed ID: 18491966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Febrile neutropenia. Etiology of infection, empirical treatment and prophylaxis.
    Eltahawy AT
    Saudi Med J; 2003 Apr; 24(4):331-6. PubMed ID: 12754528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral complications in cancer chemotherapy, cancer incidence, and mortality in the U.S.
    Dale RA; Harrison JS; Redding SW
    Gen Dent; 2004; 52(1):64-71; quiz 72. PubMed ID: 15055674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prophylaxis and treatment of infection in the bone marrow transplant recipient.
    Winston DJ
    Curr Clin Top Infect Dis; 1993; 13():293-321. PubMed ID: 8397916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral complications from cancer therapy: Part 1--Pathophysiology and secondary complications.
    Madeya ML
    Oncol Nurs Forum; 1996 Jun; 23(5):801-7. PubMed ID: 8792349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Detection of drug resistant bacteria and correspondence of microbiological laboratory to clinical physicians].
    Komori T
    Rinsho Byori; 2002 Sep; 50(9):860-8. PubMed ID: 12386963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prevention of oral diseases in children with acute leukaemia].
    Ivanović M; Jovcić O; Mandić J; Bogetić D; Maddalone M
    Srp Arh Celok Lek; 2011; 139(3-4):242-7. PubMed ID: 21626773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The photobiology of microbial pathogenesis.
    Idnurm A; Crosson S
    PLoS Pathog; 2009 Nov; 5(11):e1000470. PubMed ID: 19956669
    [No Abstract]   [Full Text] [Related]  

  • 32. Oral complications of cancer therapies. Surveillance cultures.
    Schimpff SC
    NCI Monogr; 1990; (9):37-42. PubMed ID: 2111468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pretreatment strategies for infection prevention in chemotherapy patients.
    Peterson DE
    NCI Monogr; 1990; (9):61-71. PubMed ID: 2111469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer departments as a source of resistant bacteria and fungi?
    Krcméry V
    Neoplasma; 1999; 46(1):3-6. PubMed ID: 10355526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Infection prevention in bone marrow transplantation and radiation patients.
    Epstein JB
    NCI Monogr; 1990; (9):73-85. PubMed ID: 2111470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral complications of cancer therapies. Oral complications in the pediatric population.
    Leggott PJ
    NCI Monogr; 1990; (9):129-32. PubMed ID: 2188150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 2.